Interventional Cardiology
Conditions
Keywords
Intra-aortic Balloon Pumps, Registry
Brief summary
Intra-aortic Balloon Pumps (IABP) have been used for roughly 50 years in Critical Care Units, Intensive Care Units, Cath labs as a way to improve systemic and coronary circulation in patients in cardiogenic shock (CS) or at high risk situation as mechanical complications stemming from myocardial infarction (MI), critical coronary stenosis, high-risk PCI, etc. Several papers recently questioned the relevance of this assistance device - namely the IABP-SHOCK II trial in CS and the CRISP-AMI trial in anterior MI without CS - resulting in the downgrading of the recommendation standards of the IABP by medical societies.
Interventions
None listed
Sponsors
Rennes University Hospital
Study design
Observational model
COHORT
Time perspective
PROSPECTIVE
Eligibility
Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No
Inclusion criteria
* Males and females at least of 18 of age; * Undergoing IABP treatment ; * Subject, relatives or legal guardian signified their non-opposition to participate in the study
Exclusion criteria
\- IABP insertion in immediate post-intervention period
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| IABP insertion rate | 1 year |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Number of cardiogenic shock | 1 year | IABP indications |
| Number of mechanical complication of acute coronary syndrome | 1 year | IABP indications |
| Number of myocardial infarction not shocked | 1 year | IABP indications |
| Number of other indications | 1 year | IABP indications |
| Survival rate following IABP insertion | 1 year | — |
| IABP-related complications rate and type | 1 year | — |
Countries
France
Contacts
PRINCIPAL_INVESTIGATORGuillaume LEURENT
Rennes University Hospital
Outcome results
None listed